Position in MRK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$179,900
+$11,494 QoQ
Shares Held
1,400
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#3,527
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. MRK ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,083 | $11,449,729 | |
| 2 | PFE |
Pfizer Inc
|
241,130 | $5,806,410 | |
| 3 | SNY |
Sanofi
|
47,681 | $2,034,071 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,160 | $399,234 | |
| 5 | AMGN |
Amgen Inc
|
530 | $191,923 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
1,400 | $179,900 | |
| 7 | LLY |
ELI LILLY & Co
|
60 | $71,965 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,054 | $60,731 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $179,900 | 1,400 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $168,406 | 1,400 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $173,679 | 1,650 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $831,242 | 9,904 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $184,442 | 2,330 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $206,448 | 2,300 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $228,804 | 2,300 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $261,188 | 2,300 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $284,740 | 2,300 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $303,485 | 2,300 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $261,648 | 2,400 | Shares | Sole | 2024-05-02 | |
| 2023-09-30 | $247,080 | 2,400 | Shares | Sole | 2024-05-02 | |
| 2023-06-30 | $288,475 | 2,500 | Shares | Sole | 2024-05-02 | |
| 2023-03-31 | $265,975 | 2,500 | Shares | Sole | 2024-05-02 | |
| 2022-12-31 | $299,565 | 2,700 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $249,748 | 2,900 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $280,074 | 3,072 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $191,832 | 2,338 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $160,944 | 2,100 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $157,731 | 2,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $163,317 | 2,100 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $177,846 | 2,307 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $114,519 | 1,400 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $116,130 | 1,400 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $108,262 | 1,400 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $107,715 | 1,400 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||